(Q53399243)

13 May 2018

title

Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma. (English)

1 reference

13 May 2018

author

Kimberly Van Zee

7

1 reference

13 May 2018

author name string

G H Ho

1

1 reference

13 May 2018

J E Calvano

2

1 reference

13 May 2018

M Bisogna

3

1 reference

13 May 2018

Z Abouezzi

4

1 reference

13 May 2018

P I Borgen

5

1 reference

13 May 2018

C Cordón-Cardó

6

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 February 2001

1 reference

13 May 2018

Breast Cancer Research and Treatment

published in

1 reference

13 May 2018

volume

65

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

225-232

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1023/a:1010686518990

exact match

0 references

cites work

Mutations in p53 as potential molecular markers for human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

The p53-mdm-2 autoregulatory feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

Mdm2 promotes the rapid degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

Regulation of p53 stability by Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

MDM2 amplification, P53 mutation, and accumulation of the P53 gene product in malignant fibrous histiocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

The MDM2 gene amplification database

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

Amplification of a gene encoding a p53-associated protein in human sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative beta transcript of the p16INK4a/MTS1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

Prognostic significance of p53 gene alterations in node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

7 January 2021

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

7 January 2021

mdm2 gene alterations and mdm2 protein expression in breast carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

7 January 2021

Mutations of the p53 gene in male breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

7 January 2021

Amplification of the mdm-2 gene and p53 abnormalities in uterine sarcomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

7 January 2021

Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010686518990

7 January 2021

Identifiers

DOI

10.1023/A:1010686518990

1 reference

13 May 2018

Dimensions Publication ID

1036681636

0 references

1 reference

13 May 2018